Urinary glycosaminoglycans in recurrent urinary tract infections in kidney transplant patients

Biomedicine and Pharmacotherapy

Volumn 53, Issue 5-6, 1999, Pages 274-277

  Stabellini, G ^a   Calastrini, C ^a   Gilli, P ^b   Bedani, P L ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b Division of Nephrology   (Italy)

Author keywords

Cyclosporin A; Glycosaminoglycans; Recurrent urinary infections

Indexed keywords

CYCLOSPORIN A; GLYCOSAMINOGLYCAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION;

EID: 0033149962     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80098-5     Document Type: Article

References (16)

1. Bartold PM, Page RC. Isolation, identification, and quantification of glycosaminoglycans synthesis in cultured human gingival fibroblasts in vitro. J Periodontol 1985 ; 20 : 284.
2. Cavari S, Vannucchi S. Heparin and heparin-related oligosaccharides inhibit proliferation of BALB/C 3T3 fibroblasts. Eur J Histochem 1993 ; 37 Suppl : 70.
3. Dietrich CP, Martins JRM, Sampaio LO, Nader HB. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias. Lab Invest 1993 ; 68 : 439.
4. de Jong JG, Heijs WM, Wevers RA. Mucopolysaccharidoses screening: Dimethylmethylene blue vs. alcian blue. Ann Clin Biochem 1994 ; 31 : 267.
5. Hesse A, Wuzel H, Vhlensieck W. Significance of glycosaminoglycans for the formation of calcium oxalate stones. Am J Kidney Dis 1991 ; 17 : 414.
6. Mariani G, Calastrini C, Carinci F, Bergamini L, Calastrini F, Stabellini G. Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival over-growth. J Periodontol 1996 ; 76 : 21.
7. Marx M, Weber M, Kohler H. Urinary secretory immunoglobulin-A in acute renal allograft rejection. Nephrol Dial Transplant 1990 ; 5 : 520.
8. Mitsuhashi H, Tsukada Y, Ono K, Naruse T. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases. Clin Nephrol 1993 ; 39 : 231.
9. Raza MW, Blackwell CC, Molyneaux P, James VS, Ogilvie MM, Inglis JM, et al. Association between secretor status and respiratory viral illness. Br Med J 1991 ; 303 : 815.
10. Reid G. Host vs. bacterial factors in the pathogenesis of urinary tract infections. In: Baillière-Tindall, ed. Nephrology Vol. II. London: Elsevier; 1988. p. 860.
11. Sawitzky D, Hampl H, Habermehl KO. Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoprotein. J Gen Virol 1990 ; 71 : 1221.
12. Suzuki Y, Yamaguchi T. Effects of hyaluronic acid on macrophage phagocytosis and active oxygen release. Agents Actions 1993 ; 38 : 32.
13. Stabellini G, Del Borrello E, De Mattei M, Calastrini C, Orsini LF, Franchina M. Glycosaminoglycans analysis in amniotic fluid and in cultured fibroblasts from normal and holoprosencephalic human embryonic organs. Prenatal Diag 1997 ; 17 : 1077.
14. Stabellini G, Farinelli R, Caruso A, De Mattei M, Nunzi L, Calastrini C, et al. Evaluation of the urinary glycosaminoglycans and secretory immunoglobulin A in patients with recurrent urinary tract infections and in urinary stone formers. Med Sci Res 1995 ; 23 : 473.
15. Stabellini G, Fiocchi O, Evangelisti R, Pagliarini A, Caruso A, Altavilla G. Cyclosporin A, effect cytoskeleton and glycosaminoglycans in human gingival fibroblasts. Immunohistochemical and biochemical evaluation. Eur J Basic Appl Histochem 1991 ; 35 : 371.
16. Werb Z, Sympson CJ, Alexander CM, Thomasset N, Lund LR, MacAuly A, et al. Extracellular matrix re-modelling and regulation of epithelial-stromal interactions during differentiation and involution. Kidney Int 1996 ; 54 Suppl : S68.